Alcon (ALC)

Last Price: 79.24 (2021-12-03)

Company Description

Alcon AG is specialized in the medical industry. The Company operates mainly as an eye care device company. Its operating segment consists of Surgical and Vision Care. Surgical portfolio includes technologies and devices for cataract, retinal, refractive surgery as well as advanced technology intraocular lenses to treat cataracts and refractive errors, such as presbyopia and astigmatism. It also includes advanced viscoelastics, surgical solutions, surgical packs and other disposable products for cataract and vitreoretinal surgery. Vision Care segment manufactures contact lenses and lens care products, such as products for dry eye, contact lens care, ocular allergies as well as ocular vitamins and redness relievers. The Company also offers continuing education for eye care professionals. Alcon AG is based in Geneva, Switzerland.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $6.83B
Net Income (Most Recent Fiscal Year) $-531.00M
PE Ratio (Current Year Earnings Estimate) 37.95
PE Ratio (Trailing 12 Months) 39.62
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) 4.79
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 2.03
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 18.09
Pre-Tax Margin (Trailing 12 Months) 4.71%
Net Margin (Trailing 12 Months) 4.11%
Return on Equity (Trailing 12 Months) 5.22%
Return on Assets (Trailing 12 Months) 3.59%
Current Ratio (Most Recent Fiscal Quarter) 2.23
Quick Ratio (Most Recent Fiscal Quarter) 1.44
Debt to Common Equity (Most Recent Fiscal Quarter) 0.21
Inventory Turnover (Trailing 12 Months) 2.15
Book Value per Share (Most Recent Fiscal Quarter) $38.55
Earnings per Share (Most Recent Fiscal Quarter) $0.54
Earnings per Share (Most Recent Fiscal Year) $1.04
Diluted Earnings per Share (Trailing 12 Months) $0.67
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Common Shares Outstanding 488.20M
Free Float --
Market Capitalization $38.68B
Average Volume (Last 20 Days) 0.67M
Beta (Past 60 Months) 0.62
Percentage Held By Insiders (Latest Annual Proxy Report) --
Percentage Held By Institutions (Latest 13F Reports) 45.28%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%